Bringing Therapies to Patients When Standard Channels Fail
When the medicine a patient needs is unavailable, unlicensed locally, or in shortage, care can stall at the ward or dispensary window. We create compliant access pathways that deliver to hospitals, specialty centers, and pharmacies when no standard route exists. This includes coordinating the right pathway, assembling documentation, managing health authority interactions, and delivering temperature-controlled products with full traceability. Clinically justified requests move from prescription to confirmed site receipt, supporting access and continuity of therapy without compromising compliance or patient safety.
In the rapidly evolving healthcare landscape, access to essential medicines often faces regulatory and supply barriers. Our treatment access solutions establish compliant, patient-specific pathways that enable access to rare, niche, or unlicensed therapies, address temporary shortages, and support cross-border supply for clinically justified cases.
Our focus is innovative patient care and continuity. Dedicated case handling and visible status, paired with secure temperature-controlled delivery, help keep access on track. Coordinating with clinical teams and aligning with regulatory requirements removes practical barriers, so treatment can proceed without delay.
We remove operational obstacles,so treatment can proceed without delay, making sure innovative treatments reach the point of care when standard channels fall short, because getting therapy to the patients who need them is what matters most.
Our Treatment Access Solutions
Individual ImportPatient-Specific Access to Non-Marketed Innovations. Expands care options with compliant access to innovative therapies approved outside the local market for clinically justified cases.
Shortage ResolutionRestore continuity of care during supply disruptions. Proactive market scanning, authority collaboration, qualified alternatives, and controlled distribution to keep care sites supplied.
Regulatory Landscape GuidancePractical clarity on country-specific routes to treatment access. Hands-on enablement across countries: regulatory guidance to move cases from request to pharmacy receipt.
Patient-first, care-centric handling
Single case owner, transparent status, and checklist documentation keep cases moving and care continuous.Speed with certainty
Bonded-warehouse release, established customs & OR workflows, and temperature-controlled last mile to hospital or pharmacy receipt.Licensed global access network.
Quality-assured sourcing with falsified-medicine safeguards, serialization, and end-to-end batch traceability.Authority-aligned, multi-country enablement.
Correct use of named-patient and shortage pathways, plus practical broker and IOR guidance as well as documentation support.Proactive access insights.
Continuous shortage and regulatory-approval monitoring, demand validation, and early qualification of alternatives to protect continuity of care.
“When a standard route isn't available, it's our job to find one that is”
Branded Drugs
Branded Drugs
Originator medicinal products approved for clinical use and protected by intellectual property rights.
Branded Drugs
Komtur Service: Licensed distribution and post-launch support are provided across approved markets to enable patient access, continuity of care, and compliant supply.
Generics
Generics
Medicinal products containing the same active substance as reference products and demonstrating bioequivalence following patent expiry.
Generics
Komtur Service: Approved multisource equivalents are supported for clinical trials, access pathways, and shortage recovery to maintain continuity of treatment.
Orphan and Ultra-Orphan Drugs
Orphan and Ultra-Orphan Drugs
Medicinal products developed for rare diseases affecting small patient populations, often supported by specific regulatory incentives.
Orphan and Ultra-Orphan Drugs
Komtur Service: Rare-disease therapies are supported through eligibility management, authority engagement, and continuity planning to ensure compliant and uninterrupted patient access.
Biosimilars
Biosimilars
Biologic medicines highly similar to approved reference biologics, with no clinically meaningful differences in safety, purity, or potency.
Biosimilars
Komtur Service: Biosimilars are supported through structured access pathways and regulatory documentation to enable compliant adoption and effective clinical use.
Cell and Gene Therapy (ATMPs)
Cell and Gene Therapy (ATMPs)
Advanced therapies based on genes, cells, or engineered tissues, including gene therapies, cell therapies, and tissue-engineered products. These therapies operate under specialised regulatory frameworks due to their complexity and transformative potential.
Cell and Gene Therapy (ATMPs)
Komtur Service: ATMPs requiring chain-of-identity, cold chain control, and site readiness are supported through tightly controlled processes to ensure product integrity, regulatory compliance, and reliable administration at clinical sites.
Controlled Substances
Controlled Substances
Medicinal products subject to special legal controls due to risks of abuse, dependence, or diversion, requiring strict handling and documentation throughout their lifecycle.
Controlled Substances
Komtur Service: Controlled medicines are managed through secure storage, controlled transport, and structured authority interfaces to ensure regulatory compliance and risk mitigation.
Veterinary Drugs
Veterinary Drugs
Medicinal products developed for the prevention, diagnosis, or treatment of diseases in animals, regulated separately from human medicines.
Veterinary Drugs
Komtur Service: Where relevant and permitted, compliant supply and execution support are provided to veterinary centres.
Nutraceuticals
Nutraceuticals
Products derived from food sources that provide health or wellness benefits beyond basic nutrition, including supplements and functional ingredients.
Nutraceuticals
Komtur Service: Licensed distribution in selected markets is supported and, where permitted under local regulation, nutraceuticals are integrated into trial protocols, patient care, and supportive therapy pathways.
Diagnostic Medical Devices
Diagnostic Medical Devices
Devices and tests used to identify, stratify, or monitor patients before or during treatment, including companion diagnostics linked to specific therapies.
Diagnostic Medical Devices
Komtur Service: Diagnostic devices are integrated into clinical workflows to support accurate data collection, operational efficiency, and compliant trial and care execution.
Therapeutic Medical Devices
Therapeutic Medical Devices
Medical devices delivering treatment through mechanical, physical, or digital means, used in both clinical and post-approval care settings.
Therapeutic Medical Devices
Komtur Service: Treatment-enabling devices are supported through site enablement, training coordination, access planning, and compliant distribution to ensure safe and effective use in clinical practice and patient support programs.